Mitsumasa Kawago

The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations

Koji Tsuta, Mitsumasa Kawago, Eisuke Inoue et al. · Lung Cancer · 2013 · 242 citations

Medicine, Oncology, Pathology +14

Expression of Squamous Cell Carcinoma Markers and Adenocarcinoma Markers in Primary Pulmonary Neuroendocrine Carcinomas

Kyohei Masai, Koji Tsuta, Mitsumasa Kawago et al. · Applied immunohistochemistry & molecular morphology · 2012 · 49 citations

Medicine, Molecular Biology, Oncology +17

Data acquisition for the histoculture drug response assay in lung cancer

Tatsuya Yoshimasu, Shoji Oura, Issei Hirai et al. · Journal of Thoracic and Cardiovascular Surgery · 2007 · 45 citations · Full text

Medicine, Cancer Biology, Oncology +6

A Theoretical Model for the Hormetic Dose-response Curve for Anticancer Agents.

Tatsuya Yoshimasu, Takuya Ohashi, Shoji Oura et al. · PubMed · 2015 · 20 citations

Medicine, Oncology, Pharmacology +13

Imbalanced Expression of IGF2 and PCSK4 Is Associated With Overproduction of Big IGF2 in SFT With NICTH: A Pilot Study

Shintaro Kawai, Hiroyuki Ariyasu, Shinsuke Uraki et al. · The Journal of Clinical Endocrinology & Metabolism · 2018 · 17 citations · Full text

Life Sciences, Biochemistry, Oncology +9